DrugPatentWatch Database Preview
Drugs in Development Information for Antipyrine
What is the drug development status for Antipyrine?
Antipyrine is an investigational drug.
There have been 5 clinical trials for Antipyrine.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.
The most common disease conditions in clinical trials are Dysmenorrhea, Turner Syndrome, and Syndrome. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Global United Pharmaceutical Corporation, and Pernix Theraputics LLC.
There are seven hundred and eighty-five US patents protecting this investigational drug and nine international patents.
Summary for Antipyrine
| US Patents | 785 |
| International Patents | 9,813 |
| US Patent Applications | 7,394 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 23 |
| Clinical Trial Progress | Phase 3 (2011-11-01) |
| Vendors | 72 |
Recent Clinical Trials for Antipyrine
| Title | Sponsor | Phase |
|---|---|---|
| Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults | Global United Pharmaceutical Corporation | Phase 2 |
| Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media | Pernix Theraputics LLC | Phase 2 |
| Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1) | Merck Sharp & Dohme Corp. | Phase 3 |
Clinical Trial Summary for Antipyrine
Top disease conditions for Antipyrine
Top clinical trial sponsors for Antipyrine
US Patents for Antipyrine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Antipyrine | Start Trial | Heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Antipyrine | Start Trial | Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders | Dana-Farber Cancer Institute, Inc. (Boston, MA) | Start Trial |
| Antipyrine | Start Trial | Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus | Seattle Genetics, Inc. (Bothell, WA) | Start Trial |
| Antipyrine | Start Trial | In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes | XENOTECH LLC (Lenexa, KS) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Antipyrine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Antipyrine | Canada | 2961033 | 2034-09-11 | Start Trial |
| Antipyrine | European Patent Office | 3192791 | 2034-09-11 | Start Trial |
| Antipyrine | Japan | WO2016039408 | 2034-09-11 | Start Trial |
| Antipyrine | World Intellectual Property Organization (WIPO) | 2016039408 | 2034-09-11 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
